KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLoans and Notes ReceivablesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherReceivables RefundsShares OutstandingShares Outstanding
Ratios

Astrana Health (ASTH) Other Gross PP&E Adjustments (2016 - 2025)

Astrana Health (ASTH) has disclosed Other Gross PP&E Adjustments for 14 consecutive years, with $46.6 million as the latest value for Q4 2025.

  • Quarterly Other Gross PP&E Adjustments rose 8347.83% to $46.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $46.6 million through Dec 2025, up 8347.83% year-over-year, with the annual reading at $46.6 million for FY2025, 8347.83% up from the prior year.
  • Other Gross PP&E Adjustments hit $46.6 million in Q4 2025 for Astrana Health, up from -$48.0 million in the prior quarter.
  • In the past five years, Other Gross PP&E Adjustments ranged from a high of $111.1 million in Q4 2022 to a low of -$49.1 million in Q1 2025.
  • Historically, Other Gross PP&E Adjustments has averaged -$8.3 million across 5 years, with a median of -$19.9 million in 2021.
  • Biggest YoY gain for Other Gross PP&E Adjustments was 8347.83% in 2025; the steepest drop was 498.12% in 2025.
  • Year by year, Other Gross PP&E Adjustments stood at $58.1 million in 2021, then skyrocketed by 91.18% to $111.1 million in 2022, then tumbled by 110.58% to -$11.8 million in 2023, then skyrocketed by 104.7% to $552000.0 in 2024, then skyrocketed by 8347.83% to $46.6 million in 2025.
  • Business Quant data shows Other Gross PP&E Adjustments for ASTH at $46.6 million in Q4 2025, -$48.0 million in Q3 2025, and -$42.8 million in Q2 2025.